Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme

Lancet. 1973 Jan 13;1(7794):72-4. doi: 10.1016/s0140-6736(73)90468-6.
No abstract available

MeSH terms

  • Adult
  • Angiotensin II / administration & dosage
  • Angiotensin II / antagonists & inhibitors*
  • Angiotensin-Converting Enzyme Inhibitors
  • Blood Pressure / drug effects
  • Bradykinin / pharmacology*
  • Dose-Response Relationship, Drug
  • Electrocardiography
  • Humans
  • Hypertension / diagnosis
  • Hypertension / drug therapy
  • Hypertension / enzymology
  • In Vitro Techniques
  • Injections, Intravenous
  • Male
  • Oligopeptides / pharmacology*
  • Oligopeptides / therapeutic use
  • Peptides / pharmacology*
  • Protease Inhibitors*
  • Time Factors
  • Venoms

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Oligopeptides
  • Peptides
  • Protease Inhibitors
  • Venoms
  • Angiotensin II
  • Bradykinin